Charta Health raises $55M to scale AI chart review for insurers
What's the deal? Charta Health has raised a $55 million Series B round to expand its AI medical chart review platform for health insurers, chief executive officer Justin Liu told Axios Pro. The San Francisco startup, founded in 2023, uses AI to review patient records before claims are submitted.
Why now? The round follows a $22 million Series A in July 2025 — a rapid step-up in funding. It also lands at $55 million above the 90th percentile for US enterprise software Series B rounds, based on 3,248 deals tracked.
What's the endgame? Charta's pitch is that reviewing records before claims are filed can improve billing accuracy for insurers and providers alike. The company says its platform cuts errors, flags compliance gaps, and surfaces missed revenue opportunities.
What could go wrong? Insurers and providers increasingly deploy AI on opposite sides of billing and reimbursement disputes. Adoption will hinge on whether Charta's reviews are seen as fair and demonstrably effective by both sides.
The signal: The round reflects a broader rush to automate payer and provider administrative work. Rivals including Brellium and Arintra have also raised sizable rounds in 2026 for AI-driven chart auditing and revenue-cycle tools.
Read more: Axios
Image credit: Generated with Gemini